- Home
- BITF vs RLAY Comparison
BITF vs RLAY Comparison
Compare BITF & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BITF
- RLAY
- Stock Information
- Founded
- BITF 2017
- RLAY 2015
- Country
- BITF Canada
- RLAY United States
- Employees
- BITF N/A
- RLAY N/A
- Industry
- BITF Finance: Consumer Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BITF Finance
- RLAY Health Care
- Exchange
- BITF Nasdaq
- RLAY Nasdaq
- Market Cap
- BITF 1.0B
- RLAY 1.1B
- IPO Year
- BITF N/A
- RLAY 2020
- Fundamental
- Price
- BITF $2.05
- RLAY $4.64
- Analyst Decision
- BITF Strong Buy
- RLAY Strong Buy
- Analyst Count
- BITF 6
- RLAY 9
- Target Price
- BITF $4.17
- RLAY $20.88
- AVG Volume (30 Days)
- BITF 45.9M
- RLAY 1.4M
- Earning Date
- BITF 11-13-2024
- RLAY 11-06-2024
- Dividend Yield
- BITF N/A
- RLAY N/A
- EPS Growth
- BITF N/A
- RLAY N/A
- EPS
- BITF N/A
- RLAY N/A
- Revenue
- BITF $182,959,000.00
- RLAY $10,006,000.00
- Revenue This Year
- BITF $56.56
- RLAY N/A
- Revenue Next Year
- BITF $121.39
- RLAY N/A
- P/E Ratio
- BITF N/A
- RLAY N/A
- Revenue Growth
- BITF 43.88
- RLAY N/A
- 52 Week Low
- BITF $1.01
- RLAY $4.48
- 52 Week High
- BITF $3.91
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- BITF 47.46
- RLAY 23.64
- Support Level
- BITF $2.05
- RLAY $5.96
- Resistance Level
- BITF $2.33
- RLAY $6.39
- Average True Range (ATR)
- BITF 0.23
- RLAY 0.34
- MACD
- BITF -0.02
- RLAY -0.12
- Stochastic Oscillator
- BITF 32.38
- RLAY 7.92
About BITF Bitfarms Ltd.
Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina, and Paraguay. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).